Impact of prophylactic ganciclovir on bronchoalveolar lavage lymphocyte numbers and phenotypes in murine cytomegalovirus-induced reactivation of Toxoplasma pneumonia

Journal of Laboratory and Clinical Medicine

Volumn 128, Issue 4, 1996, Pages 384-391

  Goetz, L ^a   Pomeroy, C ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0030258013     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(96)80010-2     Document Type: Article

References (31)

1. Gorensek MJ Stewart RW Keys TF McHenry MC Babiak T Goormastic M Symptomatic cytomegalovirus infection as a significant risk factor for major infections after cardiac transplantation J Infect Dis 158 1988 884 887
2. Rand KH Pollard RB Merigan TC Increased pulmonary superinfection in cardiac transplant patients undergoing primary cytomegalovirus infection N Engl J Med 298 1978 951 953
3. Schooley RT Hirsch MS Colvin RB Association of herpes virus infections with T lymphocyte subset alterations, glomerulopathy and opportunistic infection after renal transplantation N Engl J Med 308 1983 307 313
4. Chatterjee SN Fiala M Weiner J Stewart JA Stacey B Warner N Primary cytomegalovirus and opportunistic infections. Incidence in renal transplant recipients JAMA 240 1978 2446 2449
5. Goodrich JM Bowden RA Fisher L Keller C Schoch G Meyers JD Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplantation Ann Intern Med 118 1993 173 178
6. Goodrich JM Mori M Gleaves CA Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation N Engl J Med 325 1991 1601 1607
7. Merigan TC Renlund DG Keay S A controlled trial of ganciclovir to prevent cytomegalovirus disease after heart transplantation N Engl J Med 326 1992 1182 1186
8. Schmidt GM Horack DA Noland J A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants N Engl J Med 324 1991 1005 1011
9. Winston DJ Ito WG Bartoni K Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplantation recipients Ann Intern Med 118 1993 179 184
10. Pomeroy C Kline S Jordan MC Filice GA Reactivation of Toxoplasma gondii by cytomegalovirus disease in mice: anti-microbial activities of macrophages J Infect Dis 160 1989 305 311
11. Banister S Pomeroy C Effect of ganciclovir on murine cytomegalovirus-induced reactivation of Toxoplasma pneumonia J Lab Clin Med 122 1993 576 580
12. Pomeroy C Filice GA Hitt JA Jordan MC Cytomegalovirus-induced reactivation of Toxoplasma gondii in mice: lung lymphocyte phenotypes and suppressor function J Infect Dis 166 1992 677 681
13. Pomeroy C Hilleren PJ Jordan MC Latent murine cytomegalovirus DNA in splenic stromal cells of mice J Virol 65 1991 3330 3334
14. Shanley JD Pomeroy C Via CS Shearer G Interstitial pneumonitis during murine cytomegalovirus infection and graft-versus-host reaction: effect of ganciclovir therapy J Infect Dis 158 1988 1391 1394
15. Rubin RH Lynch P Pasternack MS Schoenfeld D Medearis DN Jr Combined antibody and ganciclovir treatment of murine cytomegalovirus-infected normal and immunosuppressed Balb/c mice Antimicrob Agents Chemother 33 1989 1975 1979
16. Ho M Immunology of cytomegalovirus: immunosuppressive effects during infections Birth Defects 20 1984 131 147
17. Hamilton JR Overall JC Glasgow LA Synergistic effect on mortality in mice with murine cytomegalovirus and Pseudomonas aeruginosa, Staphylococcus aureus or Candida albicans in mice Infect Immun 14 1976 982 989
18. Bale JF Kern ER Overall JC Glasgow LA Enhanced susceptibility of mice infected with murine cytomegalovirus to intranasal challenge with Escherichia coli J Infect Dis 145 1982 525 531
19. Carney WP Hirsch MS Mechanisms of immunosuppression in cytomegalovirus mononucleosis J Infect Dis 144 1981 47 54
20. Rinaldo CR Carney WP Richter BS Black PH Hirsch MS Mechanisms of immunosuppression in cytomegalovirus mononucleosis J Infect Dis 141 1980 488 495
21. Gehrz RC Marker SC Knorr SO Kalis JM Balfour HH Specific cell-mediated immune defect in active cytomegalovirus infection of young children and their mothers Lancet 2 1977 844 847
22. Schrier RD Rice GPA Oldstone MBA Suppression of natural killer cell activity and T cell proliferation by fresh isolates of human cytomegalovirus J Infect Dis 153 1986 1084 1091
23. Quinnan GV Kirmani N Esber E HLA-restricted cytotoxic T lymphocyte and non-thymic cytotoxic lymphocyte responses to cytomegalovirus infections of bone marrow transplant recipients J Immunol 126 1981 2036 2041
24. Schrier RD Oldstone MBA Recent clinical isolates of cytomegalovirus suppress human cytomegalovirus-specific human leukocyte antigen-restricted cytotoxic T-lymphocyte activity J Virol 59 1986 127 131
25. Kapasi K Rice GPA Role of the monocyte in cytomegalovirus-mediated immunosuppression in vitro J Infect Dis 154 1986 881 884
26. Bale JF O'Neil ME Detection of murine cytomegalovirus DNA in circulating leukocytes harvested during acute infection of mice J Virol 63 1989 2667 2673
27. Mercer JA Wiley CA Spector DH Pathogenesis of murine cytomegalovirus infection: identification of infected cells in the spleen during acute and latent infections J Virol 62 1988 987 997
28. Olding LB Jensen FC Oldstone MBA Pathogenesis of cytomegalovirus infection: activation of virus from bone marrow derived lymphocytes by in vitro allogeneic reactivation J Exp Med 141 1975 561 572
29. Jordan MC Mar V Spontaneous activation of murine cytomegalovirus from murine spleen explants. Role of lymphocytes and macrophages in release and replication virus J Clin Invest 70 1982 762 768
30. de la Torre JC Borrow P Oldstone MB Viral persistence and disease: cytopathology in the absence of cytolysis Br Med Bull 47 1991 838 851
31. Pomeroy C Filice GA Clabots CR Ricciputi PE Compartmentalization of lung γ -interferon production: importance in a mouse model of CMV-associated opportunistic pneumonia Thirty-fifth Interscience Conference on Antimicrobial Agents and Chemotherapy San Francisco, CA 1995